Our group previously found that selectively deleting the TGF-β type II receptor (TβRII) in proximal tubule cells worsened the response to murine models of CKD, and this was associated with altered cell cycle progression in tubular cells in vitro (5). The gene discussed is TGFBR2; the disease is chronic kidney disease.